These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 28735628)
1. Novel algorithm including CA-125, HE4 and body mass index in the diagnosis of endometrial cancer. Knific T; Osredkar J; Smrkolj Š; Tonin I; Vouk K; Blejec A; Frković Grazio S; Rižner TL Gynecol Oncol; 2017 Oct; 147(1):126-132. PubMed ID: 28735628 [TBL] [Abstract][Full Text] [Related]
2. Utility of HE4 to identify patients with endometrioid endometrial cancer who may require lymphadenectomy. Dobrzycka B; Mackowiak-Matejczyk B; Terlikowska KM; Kinalski M; Terlikowski SJ Adv Med Sci; 2016 Mar; 61(1):23-7. PubMed ID: 26344910 [TBL] [Abstract][Full Text] [Related]
3. Serum HE4 as a prognostic marker in endometrial cancer--a population based study. Brennan DJ; Hackethal A; Metcalf AM; Coward J; Ferguson K; Oehler MK; Quinn MA; Janda M; Leung Y; Freemantle M; ; Webb PM; Spurdle AB; Obermair A Gynecol Oncol; 2014 Jan; 132(1):159-65. PubMed ID: 24211402 [TBL] [Abstract][Full Text] [Related]
4. [Clinical value of combined detection of serum human epididymal secretory protein E4 and CA(125) in the diagnosis of endometrial carcinoma]. Zhang AM; Zhang P Zhonghua Fu Chan Ke Za Zhi; 2012 Feb; 47(2):125-8. PubMed ID: 22455745 [TBL] [Abstract][Full Text] [Related]
5. HE4 and CA125 levels in the preoperative assessment of endometrial cancer patients: a prospective multicenter study (ENDOMET). Antonsen SL; Høgdall E; Christensen IJ; Lydolph M; Tabor A; Loft Jakobsen A; Fagö-Olsen CL; Andersen ES; Jochumsen K; Høgdall C Acta Obstet Gynecol Scand; 2013 Nov; 92(11):1313-22. PubMed ID: 24032654 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic values of preoperative serum levels of YKL-40, HE-4 and DKK-3 in endometrial cancer. Kemik P; Saatli B; Yıldırım N; Kemik VD; Deveci B; Terek MC; Koçtürk S; Koyuncuoğlu M; Saygılı U Gynecol Oncol; 2016 Jan; 140(1):64-9. PubMed ID: 26607777 [TBL] [Abstract][Full Text] [Related]
7. CA125 and HE4 levels in a Czech female population diagnosed with endometrial cancer in preoperative management. Presl J; Novotny Z; Topolcan O; Vlasak P; Kucera R; Fuchsova R; Vrzalova J; Betincova L; Svobodova S Anticancer Res; 2014 Jan; 34(1):327-31. PubMed ID: 24403483 [TBL] [Abstract][Full Text] [Related]
8. Serum HE4 is correlated to prognostic factors and survival in patients with endometrial cancer. Stiekema A; Lok C; Korse CM; van Driel WJ; van der Noort V; Kenter GG; Van de Vijver KK Virchows Arch; 2017 Jun; 470(6):655-664. PubMed ID: 28401338 [TBL] [Abstract][Full Text] [Related]
9. Predictive value of serum HE4 and CA125 concentrations for lymphatic metastasis of endometrial cancer. Wang Y; Han C; Teng F; Bai Z; Tian W; Xue F Int J Gynaecol Obstet; 2017 Jan; 136(1):58-63. PubMed ID: 28099710 [TBL] [Abstract][Full Text] [Related]
10. Importance of Preoperative Knowledge of the Biomarker HE4 in Early-stage Endometrial Cancer Regarding Surgical Management. Presl J; Ovesna P; Novotny Z; Vlasak P; Bouda J; Kostun J; Topolcan O; Kucera R; Bednarikova M; Weinberger V Anticancer Res; 2017 May; 37(5):2697-2702. PubMed ID: 28476847 [TBL] [Abstract][Full Text] [Related]
11. Clinical Significance of Serum HE4, CA125, CA724, and CA19-9 in Patients With Endometrial Cancer. Bian J; Sun X; Li B; Ming L Technol Cancer Res Treat; 2017 Aug; 16(4):435-439. PubMed ID: 27562869 [TBL] [Abstract][Full Text] [Related]
12. The Value of Preoperative CA 125 Levels in Prediction of Myometrial Invasion in Patients with Early-stage Endometrioid- type Endometrial Cancer. Atguden Z; Yildiz A; Aksut H; Yalcin SE; Yalcin Y; Uysal D; Yetimalar H Asian Pac J Cancer Prev; 2016; 17(2):497-501. PubMed ID: 26925634 [TBL] [Abstract][Full Text] [Related]
13. HE4 is superior to CA125 in the detection of recurrent disease in high-risk endometrial cancer patients. Abbink K; Zusterzeel PL; Geurts-Moespot AJ; Herwaarden AEV; Pijnenborg JM; Sweep FC; Massuger LF Tumour Biol; 2018 Feb; 40(2):1010428318757103. PubMed ID: 29463191 [TBL] [Abstract][Full Text] [Related]
14. The role of HE4 and CA125 in differentiation between malignant and non-malignant endometrial pathologies. Abdalla N; Pazura M; Słomka A; Piórkowski R; Sawicki W; Cendrowski K Ginekol Pol; 2016; 87(12):781-786. PubMed ID: 28098927 [TBL] [Abstract][Full Text] [Related]
15. Predictive value of serum human epididymis protein 4 and cancer antigen 125 concentrations in endometrial carcinoma. Saarelainen SK; Peltonen N; Lehtimäki T; Perheentupa A; Vuento MH; Mäenpää JU Am J Obstet Gynecol; 2013 Aug; 209(2):142.e1-6. PubMed ID: 23583212 [TBL] [Abstract][Full Text] [Related]
16. [The importance of HE4 in differential diagnosis of endometrial cancer]. Minář L; Klabenešová I; Jandáková E Ceska Gynekol; 2015 Aug; 80(4):256-63. PubMed ID: 26265413 [TBL] [Abstract][Full Text] [Related]
17. The role of novel biomarker HE4 in endometrial cancer: a case control prospective study. Angioli R; Plotti F; Capriglione S; Montera R; Damiani P; Ricciardi R; Aloisi A; Luvero D; Cafà EV; Dugo N; Angelucci M; Benedetti-Panici P Tumour Biol; 2013 Feb; 34(1):571-6. PubMed ID: 23179397 [TBL] [Abstract][Full Text] [Related]
18. Serum HE4 superior to CA125 in predicting poorer surgical outcome of epithelial ovarian cancer. Shen Y; Li L Tumour Biol; 2016 Nov; 37(11):14765-14772. PubMed ID: 27629144 [TBL] [Abstract][Full Text] [Related]
19. Preoperative Serum Human Epididymis Protein 4 Levels in Early Stage Endometrial Cancer: A Prospective Study. Fanfani F; Restaino S; Cicogna S; Petrillo M; Montico M; Perrone E; Radillo O; De Leo R; Ceccarello M; Scambia G; Ricci G Int J Gynecol Cancer; 2017 Jul; 27(6):1200-1205. PubMed ID: 28557834 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of human epididymis protein 4 in endometrial cancer and its utility for surgical staging. Minar L; Klabenesova I; Jandakova E; Zlamal F; Bienertova-Vasku J J Obstet Gynaecol Res; 2015 Oct; 41(10):1644-52. PubMed ID: 26223178 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]